Brigit Biofarmaka Teknologi Tbk. vs Rockfields Properti Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Rockfields Properti Indonesia Tbk. trades at Rp1,840 (market cap 2.7T, 22.7K 24h volume). The key difference: Rockfields Properti Indonesia Tbk. is far larger — about 15.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 22.7K). Which is the better fit depends on your goals.
| OBAT | ROCK | |
|---|---|---|
Market Cap | 172.82B | 2.7T |
Volume | 592.2K | 22.7K |
Lot | 5.92K | 227 |
Turnover | 147.05M | 41.74M |
Average Price | 248.31 | 1,838.79 |
Value | 147.05M | 41.74M |
Indicative Equilibrium Price | 254 | 1,840 |
Indicative Equilibrium Volume | 10 | 8 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Rockfields Properti Indonesia, Tbk (formerly PT Nobel Properti Kencana) (“the Company” or “Holding Company”) was established in Republic of Indonesia based on the Notarial Deed No. 29 dated May 16, 2013 of Subiyanto Putro, S.H., M.Kn., Notary in Jakarta. The Company has commercially operated in April 2019.
Read more on ROCK →